During the past decade, CHU de Nantes conducted 704 clinical trials. In the 10-year time frame, 704 clinical trials started and 45 clinical trials were completed, i.e. on average, 6.4% percent of trials that started reached the finish line to date. In the past 5 years, 347 clinical trials started and 32 clinical trials were completed. i.e. 9.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Nantes" #1 sponsor was "Nantes University Hospital" with 420 trials, followed by "University Hospital, Brest" with 35 trials sponsored, "Rennes University Hospital" with 34 trials sponsored, "Centre Hospitalier Departemental Vendee" with 18 trials sponsored and "University Hospital, Toulouse" with 18 trials sponsored. Other sponsors include 471 different institutions and companies that sponsored additional 218 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Nantes" #1 collaborator was "Ministry of Health, France" with 30 trials as a collaborator, "University Hospital, Angers" with 10 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 9 trials as a collaborator, "Rennes University Hospital" with 8 trials as a collaborator and "Nantes University Hospital" with 6 trials as a collaborator. Other collaborators include 401 different institutions and companies that were collaborators in the rest 314 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Nantes" are "Multiple Myeloma" (20 trials), "Multiple Sclerosis" (14 trials), "Acute Myeloid Leukemia" (11 trials), "Cystic Fibrosis" (10 trials) and "Peripheral Arterial Disease" (9 trials). Many other conditions were trialed in "CHU de Nantes" in a lesser frequency.

Most popular intervention types in "CHU de Nantes" are "Drug" (336 trials), "Other" (297 trials), "Device" (118 trials), "Procedure" (114 trials) and "Biological" (36 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Dexamethasone" (15 trials), "Non interventional study" (15 trials), "Azacitidine" (11 trials) and "Lenalidomide" (11 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Nantes" are 949 trials for "All" genders, 38 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 325 active trials in "CHU de Nantes". 23 are not yet recruiting, 230 are recruiting, 71 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 485 completed trials in CHU de Nantes, 1 suspended trials, and 89 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Nantes, 58 "Phase 1" clinical trials were conducted, 153 "Phase 2" clinical trials and 157 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 287 trials that are defined as “Not Applicable".

CHU de Nantes has several departments that took part in Clinical trials: "Hôpital Guillaume et René Laënnec; Service Neurologie" - 9 trials, "CHU Nantes - Hôpital Guillaume et René Laënnec - Service de Pneumologie" - 6 trials, "CHU de Nantes - Dermatologie" - 5 trials, "CHU NANTES - Hôtel Dieu; Pharmacy" - 5 trials, "CHU de Nantes; Cancéro-dermatologie" - 4 trials, "Department of Physical Medicine and Locomotive Rehabilitation (Nantes University Hospital)" - 2 trials, "Hopital Hotel Dieu Et HME; Nephrologie Immunologie Clinique" - 2 trials, "CHU-Service de Réanimation Pédiatrique / Néonatalogie, Consultation spécialisée en Maladies Héréditaires du Métabolisme" - 2 trials